PSP Projects Ltd posts a consolidated PAT of Rs. 24.90 crore as of Q1FY22

PSP Projects Ltd has published its financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) – QoQ Comparison

The company reported total income of Rs. 320.88 crore during the period ended June 30, 2021 compared to Rs. 504.36 crore during the period ended March 31, 2021.

The company posted a net profit / (loss) of Rs. 24.90 crore for the period ended June 30, 2021 compared to a net profit / (loss) of Rs. 41.73 crore for the period ended March 31 2021.

The company reported EPS of 6.92 rupees for the period ended June 30, 2021, compared to 11.60 rupees for the period ended March 31, 2021.

Total revenue 320.88 crs ₹ 504.36 crs -36.38%
Net profit ₹ 24.90 cents ₹ 41.73 crs Check mark down -40.33%
EPS 6.92 11.60 Check mark down -40.34%

Financial Results (Q1 FY 2021-2022) – Year-over-year comparison

The company reported total income of Rs. 320.88 crore during the period ended June 30, 2021 compared to Rs. 111.76 crore during the period ended June 30, 2020.

The company posted a net profit / (loss) of Rs. 24.90 crore for the period ended June 30, 2021 compared to a net profit / (loss) of Rs. (3.44) crore for the period ended June 30, 2021. June 30, 2020.

The company reported EPS of 6.92 rupees for the period ended June 30, 2021 compared to (0.96 rupees) for the period ended June 30, 2020.

Total revenue 320.88 crs 111.76 crs Check mark up 187.12%
Net profit ₹ 24.90 cents (3.44) crs Check mark up 823.84%
EPS 6.92 (0.96) Check mark up 820.83%

PSP Projects Ltd shares were last trading on BSE at Rs. 469 from the previous close of Rs. 460.55. The total number of shares traded during the day was 13,029 in over 932 trades.

The share hit an intraday high of Rs. 479.1 and an intraday low of 463.7. The net turnover during the day was Rs. 6,107,741.


Source link

About Sara Rodriquez

Check Also

Canadian epilepsy community identifies top 10 research priorities

The Top 10 initiative was led by EpLink – the Ontario Brain Institute’s epilepsy research …

Leave a Reply

Your email address will not be published. Required fields are marked *